19 Multiple Sclerosis Clinical Trials in Aurora, IL (2026)

Q: How do I join a clinical trial in Aurora?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Aurora research site will contact you.

Recruiting Multiple Sclerosis Studies in Aurora

NCT00900198Recruiting

Collection of Tissue Samples for Cancer Research

Background: -Patients who are being evaluated and/or treated at the NIH Clinical Center and adult patients at participating sites will be entered onto this tissue procurement protocol for collection ...

Aurora, IL5,000 participantsNational Cancer Institute (NCI)

View Study Details

NCT01585675Recruiting

Specimen Banking From Patients With Lung Cancer

The primary objective of the protocol is to develop a comprehensive specimen banking program from patients with lung cancer for future translation research, which will enable the investigators to dete...

Aurora, IL2,000 participantsUniversity of Colorado, Denver

View Study Details

NCT06131840Recruiting

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

This clinical trial is studying advanced solid tumors. Solid tumors are cancers that start in a part of your body like your lungs or liver instead of your blood. Once tumors have grown bigger in one p...

Aurora, IL914 participantsSeagen, a wholly owned subsidiary of Pfizer

View Study Details

NCT05658497Recruiting

Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)

The primary objectives of the study are to estimate the risk of major congenital malformations (MCMs) in infants born to women with multiple sclerosis (MS) who were exposed to diroximel fumarate (DRF)...

Aurora, IL908 participantsBiogen

View Study Details

NCT07225946Recruiting

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

The purpose of this study is to find out whether treatment with pasritamig and docetaxel prolongs radiographic progression free survival (rPFS) (the length of time from start of treatment until diseas...

Aurora, IL800 participantsJanssen Research & Development, LLC

View Study Details

NCT01580982Recruiting

Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer

The mechanisms of sensitivity and resistance to oncogene-targeted therapy can be determined from tumor tissue or tumor cell lines derived from available archival samples and/or from standard-of-care r...

Aurora, IL500 participantsUniversity of Colorado, Denver

View Study Details

NCT06884618Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)

This study aims to evaluate the safety and tolerability of RO7673396 in participants with advanced solid tumors harboring RAS mutation(s). This study consists of two stages: Stage 1 (Dose Escalation) ...

Aurora, IL405 participantsHoffmann-La Roche

View Study Details

NCT07525843Recruiting

A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study

The goal of this pragmatic clinical trial is to learn if the WE BEAT program, a 5-week group-based online wellbeing and skill-building program, can help teens with congenital heart disease (CHD) impro...

Aurora, IL390 participantsCarelon Research

View Study Details

NCT06095089Recruiting

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

The purpose of Parts 1, 2A, and 2B of the study is to determine the recommended regimen for Phase 2 (RP2Rs) of combination of JNJ-87189401 with JNJ-78278343 and the purpose of Part 2C of this study is...

Aurora, IL355 participantsJanssen Research & Development, LLC

View Study Details

NCT07011914Recruiting

Care in Multiple Sclerosis (MS)

This study is structured around three main aims. In Aim 1, investigators will conduct community-based participatory research (CBPR) to develop culturally tailored methods to assess childhood adversit...

Aurora, IL300 participantsNYU Langone Health

View Study Details

NCT06663319Recruiting

A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

The purpose of this study is to determine the putative recommended phase 2 dose(s) (RP2Ds) and best way to take (optimal route of administration) JNJ-89402638 and to determine the safety of JNJ-894026...

Aurora, IL260 participantsJanssen Research & Development, LLC

View Study Details

NCT06150157Recruiting

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

The purpose of this study is to characterize safety and to determine the Recommended Phase 2 Dose (RP2D\[s\]) and optimal dosing schedule(s) of JNJ-88549968 in part 1 (Dose Escalation); to characteriz...

Aurora, IL241 participantsJanssen Research & Development, LLC

View Study Details

NCT06782490Recruiting

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986368 in participants with Multiple Sclerosis Spasticity...

Aurora, IL200 participantsCelgene

View Study Details

NCT04047628Recruiting

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

This is a multi-center prospective rater-masked (blinded) randomized controlled trial of 156 participants, comparing the treatment strategy of Autologous Hematopoietic Stem Cell Transplantation (AHSCT...

Aurora, IL156 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT06220201Recruiting

A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

The purpose of this study is to evaluate the safety, tolerability, efficacy, and drug levels of CC-97540 in participants with Relapsing Forms of Multiple Sclerosis (RMS), Progressive Forms of Multiple...

Aurora, IL120 participantsJuno Therapeutics, Inc., a Bristol-Myers Squibb Company

View Study Details

NCT06529406Recruiting

Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod

A multi-center pilot study to evaluate safety and efficacy of ozanimod as de-escalation therapy in clinically stable MS patients previously treated with anti-CD20 therapy....

Aurora, IL100 participantsUniversity of Colorado, Denver

View Study Details

NCT05433103Recruiting

Blood Flow Restriction And Veterans With MS

There currently is a lack of evidence to support exercise interventions in people with advanced disability due to MS (i.e., need assistance to walk or use a wheelchair). This project proposes to study...

Aurora, IL58 participantsVA Office of Research and Development

View Study Details

NCT07213609Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

Solid tumours are abnormal lumps of tissue that can occur in different parts of the body. The tumours involved in this study have specific genetic characteristics that can make them more aggressive an...

Aurora, IL47 participantsGlaxoSmithKline

View Study Details

NCT07224373Recruiting

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

This trial is a Phase 1b, open-label, multi-center, clinical study of AZD0120, a BCMA/CD19 dual targeting CAR+ T-cell therapy, to evaluate the safety and tolerability in adult participants with Multip...

Aurora, IL24 participantsAstraZeneca

View Study Details

About Multiple Sclerosis Clinical Trials in Aurora

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 19 multiple sclerosis clinical trials recruiting participants in Aurora, IL. These studies are seeking a combined 12,778 participants. Research is being sponsored by National Cancer Institute (NCI), University of Colorado, Denver, Seagen, a wholly owned subsidiary of Pfizer and 11 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in Aurora — FAQ

Are there multiple sclerosis clinical trials in Aurora?

Yes, there are 19 multiple sclerosis clinical trials currently recruiting in Aurora, IL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Aurora?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Aurora research site will contact you about next steps.

Are clinical trials in Aurora free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Aurora studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 19 active trials in Aurora are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated July 13, 2026 from ClinicalTrials.gov